Josephine Salimu
Cardiff, WLS, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
CD25-Treg-depleting antibodies preserving IL-2 signaling on effector T cells enhance effector activation and antitumor immunity.
Journal: Nature cancer
Published: March 01, 2021
Resistance to HER2-targeted anti-cancer drugs is associated with immune evasion in cancer cells and their derived extracellular vesicles.
Journal: Oncoimmunology
Published: June 22, 2017
Dominant immunosuppression of dendritic cell function by prostate-cancer-derived exosomes.
Journal: Journal of extracellular vesicles
Published: March 13, 2017
Cross-Presentation of the Oncofetal Tumor Antigen 5T4 from Irradiated Prostate Cancer Cells--A Key Role for Heat-Shock Protein 70 and Receptor CD91.
Journal: Cancer immunology research
Published: April 24, 2014
Tumor stroma-derived factors skew monocyte to dendritic cell differentiation toward a suppressive CD14+ PD-L1+ phenotype in prostate cancer.
Journal: Oncoimmunology
Published: April 16, 2014
Enhancement of T cell responses as a result of synergy between lower doses of radiation and T cell stimulation.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: March 07, 2014
Overexpression and potential targeting of the oncofoetal antigen 5T4 in malignant pleural mesothelioma.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: January 10, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026